EFFECT OF 6-MONTH ISOTRETINOIN TREATMENT ON 25-HYDROXYVITAMIN D LEVELS IN PATIENTS WITH ACNE VULGARIS

Basit Öğe Kaydı
dc.authorwosidSarac, Gulbahar/ABF-3119-2020
dc.contributor.authorSarac, G.
dc.contributor.authorKoca, T. T.
dc.contributor.authorSener, S.
dc.date.accessioned2024-08-04T20:57:44Z
dc.date.available2024-08-04T20:57:44Z
dc.date.issued2017
dc.departmentİnönü Üniversitesien_US
dc.descriptionWCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases -- MAR 23-26, 2017 -- Florence, ITALYen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipWCO,Int Osteoporosis Fdn,European Soc Clin & Econ Aspects Osteoporosis & Osteoarthritis,Sinklar Conf Management B V,Mylan,Radius,Hologic,Medi,Bruno,IBSA,AMGEN,ABIOGEN Pharma,Lilly,Wisepress com,Pierre Fabre,TRB Chemedica SA,UCB,OsteoSys,Quibim,Peptan,European Milk Forum,Global Dairy Platform,Cerin Org,GE,EchoLight,Kyowa Kirin & Ultragenyx Pharmaceut,EFFR,Galgo Med,Bindex,Medimaps,Yuria Pharm,Aptissen,Alexion,AgNovos Healthcare GmbH,Biomed Technologiesen_US
dc.identifier.endpageS396en_US
dc.identifier.issn0937-941X
dc.identifier.issn1433-2965
dc.identifier.startpageS396en_US
dc.identifier.urihttps://hdl.handle.net/11616/102884
dc.identifier.volume28en_US
dc.identifier.wosWOS:000406278600699en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherSpringer London Ltden_US
dc.relation.ispartofOsteoporosis Internationalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleEFFECT OF 6-MONTH ISOTRETINOIN TREATMENT ON 25-HYDROXYVITAMIN D LEVELS IN PATIENTS WITH ACNE VULGARISen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu